Compare Stocks

→ The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EMH Emerald Health Therapeutics	C$0.26 -3.8%	C$0.26	C$0.15 ▼ C$0.53	C$52.28M	N/A	644,760 shs	384,329 shs
OKYO OKYO Pharma	$1.47 +1.4%	$1.45	$0.92 ▼ $3.25	$42.38M	0.04	151,948 shs	11,767 shs
SBM ProShares Short Basic Materials	$46.38	$46.38	$42.85 ▼ $55.15	$1.86M	N/A	3,024 shs	N/A
TRX TRX Gold	$0.46 +2.2%	$0.40	$0.31 ▼ $0.60	$128.55M	0.65	341,807 shs	162,288 shs

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EMH Emerald Health Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%
OKYO OKYO Pharma	+2.84%	-1.36%	+0.69%	-8.81%	+14.17%
SBM ProShares Short Basic Materials	0.00%	0.00%	0.00%	0.00%	-0.01%
TRX TRX Gold	+1.61%	-0.28%	+23.34%	+35.43%	-14.30%

The Next Step of Their Control Is Here … (Ad)

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OKYO OKYO Pharma	3.1431 of 5 stars	3.5	5.0	0.0	0.0	2.8	1.7	0.6
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TRX TRX Gold	3.3954 of 5 stars	3.5	0.0	0.0	0.0	3.2	0.0	3.1

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A
OKYO OKYO Pharma	3.00	Buy	$7.00	376.16% Upside
SBM ProShares Short Basic Materials	0.00	N/A	N/A	N/A
TRX TRX Gold	3.00	Buy	$1.58	241.72% Upside

Current Analyst Ratings

Latest EMH, OKYO, OBD, SBM, and TRX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/16/2024	TRX TRX Gold	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1.50 ➝ $1.75
4/16/2024	TRX TRX Gold	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1.30 ➝ $1.40
3/22/2024	OKYO OKYO Pharma	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$6.00 ➝ $7.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EMH Emerald Health Therapeutics	C$13.02M	4.02	C$0.33 per share	0.78	C$0.40 per share	0.64
OKYO OKYO Pharma	N/A	N/A	N/A	N/A	($0.08) per share	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A	N/A
TRX TRX Gold	$38.32M	3.35	$0.01 per share	34.69	$0.23 per share	2.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EMH Emerald Health Therapeutics	N/A	-C$0.70	N/A	∞	N/A	N/A	N/A	N/A	N/A
OKYO OKYO Pharma	-$13.27M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	8/20/2024 (Estimated)
SBM ProShares Short Basic Materials	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TRX TRX Gold	$2.25M	$0.01	46.14	5.76	N/A	0.70%	-1.66%	-1.18%	N/A

Latest EMH, OKYO, OBD, SBM, and TRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/12/2024	Q2 2024	TRX TRX Gold	N/A	$0.01	+$0.01	N/A	$9.40 million	$7.98 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EMH Emerald Health Therapeutics	N/A	N/A	N/A	N/A	N/A
OKYO OKYO Pharma	N/A	N/A	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A	N/A	N/A
TRX TRX Gold	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EMH Emerald Health Therapeutics	35.45	2.97	2.61
OKYO OKYO Pharma	N/A	N/A	N/A
SBM ProShares Short Basic Materials	N/A	N/A	N/A
TRX TRX Gold	N/A	0.93	0.59

Ownership

Institutional Ownership

Company	Institutional Ownership
EMH Emerald Health Therapeutics	N/A
OKYO OKYO Pharma	2.97%
SBM ProShares Short Basic Materials	N/A
TRX TRX Gold	1.06%

Insider Ownership

Company	Insider Ownership
EMH Emerald Health Therapeutics	N/A
OKYO OKYO Pharma	40.46%
SBM ProShares Short Basic Materials	N/A
TRX TRX Gold	2.25%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
EMH Emerald Health Therapeutics	161	205.03 million	N/A	Not Optionable
OKYO OKYO Pharma	8	28.83 million	17.17 million	Not Optionable
SBM ProShares Short Basic Materials	N/A	40,000	N/A	Not Optionable
TRX TRX Gold	130	278.92 million	272.64 million	Optionable

EMH, OKYO, OBD, SBM, and TRX Headlines

Source	Headline
	RAM TRX Final Edition revealed goldcoastbulletin.com.au - April 26 at 6:26 PM
	2024’s Best Bitcoin Casinos – Top 10 Crypto Casino Sites For BTC Games outlookindia.com - April 26 at 4:00 AM
	TRX Gold (NYSE:TRX) Coverage Initiated by Analysts at StockNews.com americanbankingnews.com - April 25 at 2:20 AM
	Shaquille O’Neal’s Armored Truck: A Unique Ride msn.com - April 24 at 5:26 PM
	Electric Ford F-150 goes on sale in Australia – for $250,000 goldcoastbulletin.com.au - April 23 at 11:24 AM
	FY2024 EPS Estimates for TRX Gold Co. Increased by Roth Capital (NYSE:TRX) americanbankingnews.com - April 20 at 2:42 AM
	Equities Analysts Offer Predictions for TRX Gold Co.'s FY2024 Earnings (NYSE:TRX) marketbeat.com - April 19 at 8:50 AM
	Roth Capital Equities Analysts Lift Earnings Estimates for TRX Gold Co. (NYSE:TRX) americanbankingnews.com - April 19 at 3:02 AM
	Roth Capital Weighs in on TRX Gold Co.'s FY2025 Earnings (NYSE:TRX) marketbeat.com - April 18 at 6:48 AM
	Is TRX Gold Corporation's (TSE:TRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? finance.yahoo.com - April 17 at 7:27 PM
	Roth MKM Keeps Their Buy Rating on Tanzanian Royalty Exploration (TRX) markets.businessinsider.com - April 17 at 2:27 PM
	TRX Gold (NYSE:TRX) Price Target Increased to $1.75 by Analysts at Alliance Global Partners americanbankingnews.com - April 17 at 4:36 AM
	TRX Gold (NYSE:TRX) Price Target Increased to $1.40 by Analysts at HC Wainwright americanbankingnews.com - April 17 at 3:48 AM
	TRX Gold (NYSE:TRX) Receives New Coverage from Analysts at StockNews.com americanbankingnews.com - April 17 at 2:14 AM
	Buy Rating Affirmed for Tanzanian Royalty Exploration Amid Strong Financials and Operational Advancements markets.businessinsider.com - April 16 at 2:03 PM
	TRX Gold (NYSE:TRX) PT Raised to $1.75 at Alliance Global Partners marketbeat.com - April 16 at 1:28 PM
	TRX Gold nears completion of plant expansion at Buckreef gold project proactiveinvestors.com - April 15 at 8:42 AM
	TRX Gold Corporation: TRX Gold Expects Significant Growth with Plant Expansion Nearing Completion finanznachrichten.de - April 15 at 7:59 AM
	TRX Gold Expects Significant Growth with Plant Expansion Nearing Completion globenewswire.com - April 15 at 6:30 AM
	Crypto Whale Incoming: Tron (TRX) And Litecoin (LTC) Exceed Expectations, Whilst Scorpion Casino (SCORP) Nears Its Official Launch outlookindia.com - April 13 at 7:45 AM
	TRX Stock Earnings: TRX Gold Misses Revenue for Q2 2024 markets.businessinsider.com - April 12 at 11:24 PM
	BlockDAG Presale Triumph: Eyeing $10 Value With 20,000x ROI Amidst TRON’s Decline And Upcoming Bitcoin Halving finbold.com - April 12 at 8:21 AM
	TRON Sees Whale Outflows; Bonk Aims For New ATH; NuggetRush Becomes Retail Favorite finbold.com - April 10 at 8:42 AM
	NuggetRush’s Presale Sparks Interest Over WIF and TRON Predictable Plays msn.com - April 7 at 1:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Emerald Health Therapeutics

CVE:EMH

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

OKYO Pharma

NASDAQ:OKYO

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead preclinical product candidate is OK-101, which is in Phase II clinical trials for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic chronic pain. The company was incorporated in 2007 and is headquartered in London, the United Kingdom.

ProShares Short Basic Materials

NYSEARCA:SBM

ProShares Short Basic Materials (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of Dow Jones U.S. Basic Materials Index (the Index). The Index measures the performance of the basic materials industry of the United States equity market. The Fund invests in derivatives as a substitute for directly shorting stocks in order to gain inverse exposure to the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. The Fund also invests in short-term cash instruments that have terms to maturity of less than 397 days and exhibit credit profiles. ProShare Advisors LLC is the investment advisor of the Fund.

TRX Gold

NYSE:TRX

TRX Gold Corporation engages in the exploration, development, and production of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project that comprises a single Special Mining License covering an area of 16.04 square kilometers and 12 Prospecting Licenses covering 98.19 square kilometers located in north-central Tanzania. The company was formerly known as Tanzanian Gold Corporation and changed its name to TRX Gold Corporation in May 2022. TRX Gold Corporation was incorporated in 1990 and is based in Oakville, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial